Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents

被引:97
作者
Xanthakos, S
Miles, L
Bucuvalas, J
Daniels, S
Garcia, V
Inge, T
机构
[1] Childrens Hosp, Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA
[3] Childrens Hosp, Med Ctr, Div Cardiol, Cincinnati, OH 45229 USA
[4] Childrens Hosp, Med Ctr, Div Pediat Surg, Cincinnati, OH 45229 USA
关键词
D O I
10.1016/S1542-3565(05)00978-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: To characterize the spectrum of nonalcoholic fatty liver disease (NAFLD) in morbidly obese adolescents, we correlated liver histology with clinical features and compared findings with reported adult data. We hypothesized that NAFLD would be less severe as a result of younger age and shorter duration of obesity, but portal inflammation and fibrosis would be more prevalent. Methods: Cross-sectional study was made of 41 adolescent subjects, 13-19 years old (mean, 16 years), 61% female, 83% non-Hispanic white, mean body mass index 59 kg/m(2), undergoing gastric bypass with liver biopsy. Liver biopsies were graded and staged as proposed by the NASH Clinical Research Network. Data were analyzed by using descriptive statistics, analysis of variance, and Fisher exact tests. Results: Eighty-three percent had NAFLD: 24% steatosis alone, 7% isolated fibrosis with steatosis, 32% nonspecific inflammation and steatosis, and 20% nonalcoholic steato-hepatitis (NASH). Twenty-nine percent had fibrosis; none had cirrhosis. Abnormal ALT (P = .05) and AST (P = .01) were more prevalent in NASH. Mean fasting glucose was significantly higher in NASH (P = .05), but prevalence of the metabolic syndrome was not significantly different. Conclusions: NAFLD was very prevalent in morbidly obese adolescents, but severe NASH was uncommon. In contrast to morbidly obese adults, lobular inflammation, significant ballooning, and perisinusoidal fibrosis were rare, whereas portal inflammation and portal fibrosis were more prevalent, even in those who did not meet criteria for NASH. These findings might support use of a modified scoring system for pediatric NASH. Presence of the metabolic syndrome in morbidly obese adolescents did not distinguish NASH from steatosis alone.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 30 条
[1]
Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]
Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery [J].
Beymer, C ;
Kowdley, KV ;
Larson, A ;
Edmonson, P ;
Dellinger, EP ;
Flum, DR .
ARCHIVES OF SURGERY, 2003, 138 (11) :1240-1244
[3]
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[4]
Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[5]
Nonalcoholic Fatty Liver Disease: A Review of Current Understanding and Future Impact [J].
Charlton, Michael .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) :1048-1058
[6]
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease [J].
Clark, JM ;
Alkhuraishi, ARA ;
Solga, SF ;
Alli, P ;
Diehl, AM ;
Magnuson, TH .
OBESITY RESEARCH, 2005, 13 (07) :1180-1186
[7]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]
Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? [J].
Crespo, J ;
Fernández-Gil, P ;
Hernández-Guerra, M ;
Cayón, A ;
Mayorga, M ;
Domínguez-Diez, A ;
Fernández-Escalante, JC ;
Pons-Romero, F .
OBESITY SURGERY, 2001, 11 (03) :254-257
[9]
Liver damage in obese patients [J].
Del Gaudio, A ;
Boschi, L ;
Del Gaudio, GA ;
Mastrangelo, L ;
Munari, D .
OBESITY SURGERY, 2002, 12 (06) :802-804
[10]
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese [J].
Dixon, JB ;
Bhathal, PS ;
O'Brien, PE .
GASTROENTEROLOGY, 2001, 121 (01) :91-100